Evidence map›Paper›PMID 31610796›Full record

ArticleGenome biology2019

Global impact of somatic structural variation on the DNA methylome of human cancers.

Yiqun Zhang, Lixing Yang, Melanie Kucherlapati, Angela Hadjipanayis, Angeliki Pantazi, Christopher A Bristow, Eunjung Alice Lee, Harshad S Mahadeshwar, Jiabin Tang, Jianhua Zhang and 13 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Kolmogorov-Arnold networks for genomic tasks.Briefings in bioinformatics · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 2 countries.

Yiqun ZhangDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Lixing YangBen May Department for Cancer Research and Department of Human Genetics, The University of Chicago, Chicago, IL, 60637, USA.
Melanie KucherlapatiDepartment of Genetics, Harvard Medical School, Boston, MA, 02115, USA.
Angela HadjipanayisDepartment of Genetics, Harvard Medical School, Boston, MA, 02115, USA.
Angeliki PantaziDepartment of Genetics, Harvard Medical School, Boston, MA, 02115, USA.
Christopher A BristowDepartment of Genomic Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Eunjung Alice LeeDivision of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Harshad S MahadeshwarDepartment of Genomic Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Jiabin TangDepartment of Genomic Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Jianhua ZhangDepartment of Genomic Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Sahil SethDepartment of Genomic Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Semin LeeCenter for Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.
Xiaojia RenDepartment of Genetics, Harvard Medical School, Boston, MA, 02115, USA.
Xingzhi SongDepartment of Genomic Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Huandong SunDepartment of Genomic Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Jonathan SeidmanDepartment of Genetics, Harvard Medical School, Boston, MA, 02115, USA.
Lovelace J LuquetteCenter for Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.
Ruibin XiCenter for Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.
Lynda ChinDepartment of Genomic Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Alexei ProtopopovSanofi US, Cambridge, MA, 02139, USA.
Peter J ParkDivision of Genetics, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Raju KucherlapatiDepartment of Genetics, Harvard Medical School, Boston, MA, 02115, USA.
Chad J CreightonDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA. creighto@bcm.edu.ORCID http://orcid.org/0000-0002-6090-703X
The University of Texas MD Anderson Cancer Center · USHarvard University · USBrigham and Women's Hospital · USBaylor College of Medicine · USBoston Children's Hospital · USBroad Institute · USSanofi (United States) · USUniversity of Chicago · USUniversity of Lethbridge · CA

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
The Cancer Genome Atlas Data Analysis CenterU24CA143845 · NCI · BROAD INSTITUTE, INC. · PI CHIN, LYNDA, GETZ, GAD A · 2009 to 2016
$16.0M
Training Program in Bioinformatics and Integrative GenomicsT32HG002295 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Peter J Park · 2001 to 2026
$15.8M
Harvard Genome Characterization CenterU24CA144025 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHERLAPATI, RAJU S. · 2009 to 2016
$14.0M
NCI NIH HHS CA125123NCI NIH HHS U24 CA143845NCI NIH HHS U24 CA144025NHGRI NIH HHS T32 HG002295
6 · The paper itself

Abstract

backgroundGenomic rearrangements exert a heavy influence on the molecular landscape of cancer. New analytical approaches integrating somatic structural variants (SSVs) with altered gene features represent a framework by which we can assign global significance to a core set of genes, analogous to established methods that identify genes non-randomly targeted by somatic mutation or copy number alteration. While recent studies have defined broad patterns of association involving gene transcription and nearby SSV breakpoints, global alterations in DNA methylation in the context of SSVs remain largely unexplored.

resultsBy data integration of whole genome sequencing, RNA sequencing, and DNA methylation arrays from more than 1400 human cancers, we identify hundreds of genes and associated CpG islands (CGIs) for which the nearby presence of a somatic structural variant (SSV) breakpoint is recurrently associated with altered expression or DNA methylation, respectively, independently of copy number alterations. CGIs with SSV-associated increased methylation are predominantly promoter-associated, while CGIs with SSV-associated decreased methylation are enriched for gene body CGIs. Rearrangement of genomic regions normally having higher or lower methylation is often involved in SSV-associated CGI methylation alterations. Across cancers, the overall structural variation burden is associated with a global decrease in methylation, increased expression in methyltransferase genes and DNA damage response genes, and decreased immune cell infiltration.

conclusionGenomic rearrangement appears to have a major role in shaping the cancer DNA methylome, to be considered alongside commonly accepted mechanisms including histone modifications and disruption of DNA methyltransferases.

Indexed as

EpigenomeGenomic Structural VariationCpG IslandsHumansNeoplasms

Identifiers

PMID31610796
PMCPMC6792267
OpenAlexW2979623390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.